- Home
- ORIC vs CAC Comparison
ORIC vs CAC Comparison
Compare ORIC & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- CAC
- Stock Information
- Founded
- ORIC 2014
- CAC 1875
- Country
- ORIC United States
- CAC United States
- Employees
- ORIC N/A
- CAC N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- CAC Major Banks
- Sector
- ORIC Health Care
- CAC Finance
- Exchange
- ORIC Nasdaq
- CAC Nasdaq
- Market Cap
- ORIC 974.1M
- CAC 688.3M
- IPO Year
- ORIC 2020
- CAC 1997
- Fundamental
- Price
- ORIC $10.90
- CAC $39.80
- Analyst Decision
- ORIC Strong Buy
- CAC Buy
- Analyst Count
- ORIC 10
- CAC 3
- Target Price
- ORIC $17.33
- CAC $48.00
- AVG Volume (30 Days)
- ORIC 895.7K
- CAC 55.1K
- Earning Date
- ORIC 11-11-2025
- CAC 10-28-2025
- Dividend Yield
- ORIC N/A
- CAC 4.17%
- EPS Growth
- ORIC N/A
- CAC 4.80
- EPS
- ORIC N/A
- CAC 3.11
- Revenue
- ORIC N/A
- CAC $197,501,000.00
- Revenue This Year
- ORIC N/A
- CAC $42.11
- Revenue Next Year
- ORIC N/A
- CAC $5.51
- P/E Ratio
- ORIC N/A
- CAC $12.93
- Revenue Growth
- ORIC N/A
- CAC 21.74
- 52 Week Low
- ORIC $3.90
- CAC $34.53
- 52 Week High
- ORIC $14.67
- CAC $50.07
- Technical
- Relative Strength Index (RSI)
- ORIC 58.48
- CAC 47.42
- Support Level
- ORIC $10.36
- CAC $39.82
- Resistance Level
- ORIC $11.16
- CAC $40.75
- Average True Range (ATR)
- ORIC 0.51
- CAC 0.79
- MACD
- ORIC 0.06
- CAC -0.06
- Stochastic Oscillator
- ORIC 74.31
- CAC 12.06
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.